Abstract: Disclosed is a low alloy steel for oil well pipes which has excellent sulfide stress cracking resistance and is suitable for casing and tubing for oil wells or gas wells. Specifically disclosed is a low alloy steel for oil well pipes containing, in mass %, 0.2-0.35% of C, 0.05-0.5% of Si, 0.05-1.0% of Mn, not more than 0.025% of P, not more than 0.01% of S, 0.005-0.10% of Al, 0.1-1.0% of Cr, 0.5-1.0% of Mo, 0.002-0.05% of Ti, 0.05-0.3% of V, 0.0001-0.005% of B, not more than 0.01% of N, not more than 0.01% of O (oxygen), 0-0.1% of Nb, 0-0.01% of Ca, 0-0.01% of Mg and 0-0.1% of Zr, and having a half-value breadth (H) and a hydrogen diffusion coefficient (D) (10?6 cm2/s) satisfying the following formula (1): 30H+D?19.5??(1).

Abstract: Using a compound selected from compounds represented by the following formula (1) (which include 3-phenyl-2-pyrazoline derivatives and 3-phenyl-tetrahydropyridazine derivatives) and pharmacologically acceptable salts thereof, an agent is provided which can activate glutamic acid transporter and which is useful for prevention and/treatment of cerebral ischemia (cerebral infarct and brain edema), amyotrophic lateral sclerosis (ALS), etc., all caused by glutamic acid toxicity.

Abstract: A quinoline derivative represented by the following formula (1): 1

Abstract: Using a compound selected from compounds represented by the following formula (1) 1

Abstract: A benzothiophene derivative represented by formula (1): 1

Abstract: The invention relates to a substituted amidine derivative which has an excellent platelet aggregation inhibiting action on the basis of fibrinogen antagonism and is particularly excellent in effectiveness on oral administration, and the platelet aggregation inhibitor containing the substituted amidine derivative of the invention as an effective ingredient is effective for prevention and treatment of thrombosis, and restenosis or reocclusion after percutaneous transluminal coronary angioplasty or percutaneous transluminal coronary recanalization.

Abstract: The invention relates to a novel compound which is represented by the formula (1) and has an excellent platelet aggregation inhibiting action based on fibrinogen antagonism. The platelet aggregation inhibitor containing the compound of the formula (1) as an effective ingredient are effective for prevention and curing of thrombosis and restenosis or reocclusion after percutaneous transluminal coronary angioplasty or percutaneous transluminal coronary recanalization.

Abstract: A signal detecting apparatus is to obtain hysteresis characteristic at a constant ratio regardless of signal amplitude fluctuations by supplying the threshold level adjusting signal corresponding to the input signal amplitude to the comparison circuit. The threshold value setting signal and the hysteresis adjusting signal is supplied to a comparison circuit through an amplifier and a hysteresis adjusting means having the identical characteristic with the peak hold circuit to set a threshold value and a hysteresis range. Therefore even in the case where the operating characteristic of the amplifier and the peak hold circuit for detecting the peak level of signal amplitude fluctuate, the threshold value and the hysteresis range fluctuation corresponding to the fluctuation. As a result, there can not need the adjustment for resetting the operating characteristic, the threshold value and the hysteresis range in each circuit and thus the time and labor required for adjustment can be further saved.